Federated Hermes, Inc. Seres Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$52.5 Billion
Q3 2025

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.33 - $5.07 $5.62 Million - $12.2 Million	-2,413,084 Reduced 21.18%	8,981,717 $21.4 Million
Q2 2023 Aug 14, 2023	SELL	$4.67 - $6.55 $18.1 Million - $25.4 Million	-3,882,555 Reduced 25.41%	11,394,801 $54.6 Million
Q1 2023 May 08, 2023	SELL	$4.95 - $6.09 $13.9 Million - $17.1 Million	-2,808,582 Reduced 15.53%	15,277,356 $86.6 Million
Q4 2022 Feb 13, 2023	SELL	$5.09 - $9.05 $2.1 Million - $3.74 Million	-413,198 Reduced 2.23%	18,085,938 $101 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $1.81 Million - $3.72 Million	516,880 Added 2.87%	18,499,136 $119 Million

Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $26.9 Million - $76 Million	9,971,450 Added 124.47%	17,982,256 $61.7 Million
Q1 2022 May 13, 2022	BUY	$6.3 - $8.84 $6.91 Million - $9.69 Million	1,096,670 Added 15.86%	8,010,806 $57 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $1.61 Million - $3.06 Million	-267,964 Reduced 3.73%	6,914,136 $57.6 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $26.4 Million - $109 Million	4,834,191 Added 205.89%	7,182,100 $50 Million
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $7.66 Million - $10.1 Million	-415,000 Reduced 15.02%	2,347,909 $56 Million
Q1 2021 May 13, 2021	SELL	$17.66 - $28.92 $3.36 Million - $5.5 Million	-190,161 Reduced 6.44%	2,762,909 $56.9 Million
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $3.8 Million - $6.17 Million	163,403 Added 5.86%	2,953,070 $72.4 Million
Q3 2020 Nov 12, 2020	BUY	$3.74 - $28.74 $6.59 Million - $50.6 Million	1,760,867 Added 171.16%	2,789,667 $79 Million
Q1 2020 May 13, 2020	BUY	$2.64 - $3.82 $1.67 Million - $2.42 Million	633,135 Added 160.02%	1,028,800 $3.67 Million
Q4 2019 Feb 14, 2020	SELL	$2.99 - $4.42 $52,193 - $77,155	-17,456 Reduced 4.23%	395,665 $1.37 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $941,680 - $1.71 Million	411,214 Added 21563.4%	413,121 $1.66 Million
Q2 2019 Aug 14, 2019	SELL	$2.28 - $7.35 $2,250 - $7,254	-987 Reduced 34.11%	1,907 $6,000
Q1 2019 May 10, 2019	SELL	$4.83 - $7.21 $8.39 Million - $12.5 Million	-1,736,334 Reduced 99.83%	2,894 $20,000
Q4 2018 Feb 13, 2019	SELL	$4.52 - $8.88 $140,242 - $275,519	-31,027 Reduced 1.75%	1,739,228 $7.86 Million
Q3 2018 Nov 13, 2018	BUY	$7.33 - $9.23 $3,049 - $3,839	416 Added 0.02%	1,770,255 $13.4 Million
Q2 2018 Aug 10, 2018	BUY	$6.91 - $9.55 $21,821 - $30,158	3,158 Added 0.18%	1,769,839 $15.2 Million
Q1 2018 May 09, 2018	BUY	$7.34 - $11.16 $1.98 Million - $3.02 Million	270,224 Added 18.06%	1,766,681 $13 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $12.64 $6.56 Million - $9.07 Million	717,451 Added 92.1%	1,496,457 $0
Q3 2017 Nov 13, 2017	BUY	$12.81 - $16.85 $9.98 Million - $13.1 Million	779,006	779,006 $12.5 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

1.78M

Call Options Held

Put Options Held

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $2.21B
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account